Danaher's latest marketcap:
As of 08/11/2025, Danaher's market capitalization has reached $143.61 B. According to our data, Danaher is the 123th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 143.61 B |
| Revenue (ttm) | 24.01 B |
| Net Income (ttm) | 3.41 B |
| Shares Out | 716.05 M |
| EPS (ttm) | 4.71 |
| Forward PE | 24.71 |
| Ex-Dividend Date | 06/27/2025 |
| Earnings Date | 07/22/2025 |
Danaher's yearly market capitalization.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 08/11/2025 | $143.61 B | -13.38% | 123 |
| 12/31/2024 | $165.8 B | -3.01% | 84 |
| 12/29/2023 | $170.94 B | -11.53% | 69 |
| 12/30/2022 | $193.22 B | -17.82% | 48 |
| 12/31/2021 | $235.1 B | 48.98% | 49 |
| 12/31/2020 | $157.8 B | 43.14% | 69 |
| 12/31/2019 | $110.24 B | 52.53% | 93 |
| 12/31/2018 | $72.28 B | 11.94% | 118 |
| 12/29/2017 | $64.57 B | 19.92% | 159 |
| 12/30/2016 | $53.84 B | -15.41% | 160 |
Company Profile
About Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services globally, with a strong presence in the United States and China. The company operates through three key segments:
Business Segments
- Biotechnology Segment: Provides bioprocessing technologies, consumables, and services for therapeutic development and manufacturing. This includes cell culture media, chromatography resins, filtration solutions, lab-scale protein purification tools, and diagnostic assay development reagents.
- Life Sciences Segment: Offers advanced instruments and solutions such as mass spectrometers, flow cytometry systems, genomics tools, microscopes, and protein consumables. Brands under this segment include ABCAM, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, and SCIEX.
- Diagnostics Segment: Delivers clinical instruments, consumables, and software for hospitals, labs, and critical care settings. Products cover clinical chemistry, immunoassay, hematology, and microbiology.
Company Background
Originally founded in 1969 as Diversified Mortgage Investors, Inc., the company rebranded as Danaher Corporation in 1984. Today, it is headquartered in Washington, D.C., and continues to drive innovation across biotechnology, life sciences, and diagnostics.
Frequently Asked Questions
-
What is Danaher's (DHR) current market cap?As of 08/11/2025, Danaher (including the parent company, if applicable) has an estimated market capitalization of $143.61 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Danaher (DHR) rank globally by market cap?Danaher global market capitalization ranking is approximately 123 as of 08/11/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.